1. 64Cu-TETA-Octreotide as a PET imaging agent for patients with neuroendocrine tumors;Anderson;J Nucl Med,2001
2. Radiotherapy, toxicity and dosimetry of copper-64-TETA-octreotide in tumor-bearing rats;Anderson;J Nucl Med,1998
3. Cure of human carcinoma xenografts by a single dose of pretargeted yttrium-90 with negligible toxicity;Axworthy;Proc Natl Acad Sci USA,2000
4. U.S. Patent 5,608,060;Axworthy,1997
5. Quantitative 68Ga-DOTATOC SMS receptor PET and planar 67Ga-DOTATOC SMS receptor scintigraphy in the pre-therapeutical dosimetry of neuroendocrine tumours;Boerner;J Nucl Med,2001